Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Snyder's-Lance acquired Diamond Foods. California Resources had a low stock price, and its low market capitalization ranked it at the bottom of the S&P MidCap 400. [266] February 9, 2016: FNB: FNB Corporation: RCII: Rent-A-Center: F.N.B. acquired Metro Bancorp. [267] February 9, 2016: SFM: Sprouts Farmers Market: SWI: SolarWinds
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
In February 2015, AMRI acquired SSCI based in West Lafayette, Indiana. SSCI was founded in 1991, providing comprehensive cGMP solid state chemistry research and analytical services to the pharmaceutical industry. Servicing more than 250 customers a year. [25] [26] In July 2015, the company acquired Gadea Pharmaceutical group for $174 million. [27]
Stock markets abroad mostly fell after President-elect Trump said he plans to impose sweeping new tariffs on Mexico, Canada and China once he takes office. Stock market today: Wall Street hits ...
The company was projected to be a global leader in over the counter medicines with a 7.3 percent market share in 2022. [5] Haleon was established on 18 July 2022 as a corporate spin-off from GSK. [6] Sir David Lewis is chairman, with Brian McNamara as CEO. [7]
Biotech and pharmaceutical companies in the New York metropolitan area represent a significant and growing economic component of the New York metropolitan area, [1] [2] the most populous combined statistical area in the United States [3] and one of the most populous megacities in the world.